Hypocalcemia After Total ThyroidectomyNCT01027091
The Study of a Safe and Cost-effective Method to Identify Patients at Low Risk of Significant Hypocalcemia After Total Thyroidectomy.
An observational study of Hypocalcemia After Total Thyroidectomy, run by G. Hatzikosta General Hospital at 1 site in Greece.
Trial summary
Hypocalcemia is the complication, after total thyroidectomy, that usually determines the length of hospital stay.Serum calcium levels is a quick and cost-effective practice to recognise hypocalcemia in the postoperative follow up. Read more about this study
- Who is it for?
- Ages 16 to 80 years
- Conditions the study is for
- Hypocalcemia After Total Thyroidectomy
- How many people
- 120 participants
- Where
- 1 siteGreece
- Study dates
- Nov 2008to Jan 2011
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 16 to 80 years
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: patients with any thyroid pathology undergoing total thyroidectomy regardless of gender, age and medication
Who may be able to join
- patients with any thyroid pathology undergoing total thyroidectomy regardless of gender, age and medication
Who cannot join
- patients treated with substitutes calcium and vitamin D.
Trial locations and contacts
1 site in 1 country.
Greece1 site, 1 recruiting
- Recruiting
G.Hatzikosta General Hospital
Ioannina, Ioannina, 45221
Evangelos K Tsimoyiannis, DR, FACS, FABI, 00302651080513, etsimogi@ath.forthnet.gr
About this study
Official title: The Study of a Safe and Cost-effective Method to Identify Patients at Low Risk for the Development of Significant Hypocalcemia After Total Thyroidectomy.
Hypocalcemia is the complication, after total thyroidectomy, that usually determines the length of hospital stay.Serum calcium levels is a quick and cost-effective practice to recognise hypocalcemia in the postoperative follow up.
OBJECTIVE: The objective of this perspective study is to determine if consecutive postoperative serum calcium levels early after total thyroidectomy can be used to identify patients who are unlikely to develop significant hypocalcemia and can be safely discharged within 24 to 48 hours postoperative.
Read the detailed description
INTRODUCTION:
In recent years there has been a global trend towards more radical and aggressive approach to thyroid surgery (total or subtotal thyroidectomy against semithyreoeidectomy), almost regardless of the pathological cause, even for benign diseases. There is also developed, a serious skepticism as complications of total or subtotal thyroidectomy is neither rare nor insignificant. In particular, complications of thyroidectomy is the laryngeal nerve paresis (0.2% bilateral, unilateral 3,7-3,9%, 2% transient, lasting 1%), bleeding (1-2%), infection of the wound (0, 3-1,6%) and hypocalcaemia (permanent hypocalcaemia in over 6 months follow up 1,7-4,4%, while transient, manageable with vit D and calcium substitution 8,3-9,9%). The post total thyroidectomy hypocalcaemia is not only more frequent but also has the most delayed onset after surgery (up to several 24hours later) in relation to bleeding and paresis of the laryngeal nerve, which is immediate postoperative complications. This is the main cause of prolonged hospitalization and monitoring of patients postoperatively which is linked to increased risk of bacterial infections and increased cost.9, 10 Great effort has been made in the last 15 years to reduce the length hospital stay of patients in order to perform the total thyroidectomy as a one day surgery.6, 11 In this way great importance is the prediction of those patients are more likely to experience post-operative hypocalcaemia. The appearance of postoperative hypocalcaemia associated with specific diseases such as thyroid disease Graves, the thyreotoxicosis and thyroid cancer 7.8, and the surgical technique (the extent of excision, the type of thyroid artery ligation, the number of parathyroid recognized intraoperative but also those autotransplanted) 12. Moreover, beyond these factors, great importance is given to methods of monitoring patients to find reliable indicators to allow safe release out of the hospital after the first 24 hours without risk of hypocalcaemia. The measurement of parathyroid hormone (PTH) both intraoperative and postoperatively (4 hours) is a hot topic in contemporary literature and promises accurate predictions 13, but there is disagreement about the precise time of receiving the specimens and great consideration about the increased cost 14, 15 (at our hospital is not even available). An older, simple, fast and economical method is to measure levels of free serum calcium 6,9. Despite that the correlation of the immediate post-operative levels of free calcium, with the likelihood of developing hypocalcaemia has variations in different surveys, resulting to early release of patients directly when free calcium is in normal range, by some departments, while others follow strict protocols of monitoring patients for days . However, the variation in the levels of free serum calcium between the first 6 and 12 postoperative hours alone or in combination with measurement of PTH seems to give some answers and it is under great consideration in the international community.
It is therefore, in line with the current literature, important to develop a safe, and also cost-effective protocol monitoring patients after total thyroidectomy, which, in combination with predisposing risk factors of hypocalcaemia, will predict low-risk patients for developing hypocalcaemia and allow secure release from the hospital.
PRIMARY OBJECTIVES:
The objective of this perspective study is to correlate the variability of the levels of free serum calcium (Ca + +), and also the levels of albumin (ALB), phosphorus (PO-3), magnesium (Mg) and total albumin (TPR), between two measurements on 6 and 12 hours postoperatively, the incidence of hypocalcaemia in patients undergoing total thyroidectomy for any reason. The aim is to develop on the basis of variation in levels of free serum calcium, a secure method of prediction and identification of low risk patients for developing hypocalcaemia providing an early release from hospital.
SECONDARY OBJECTIVES:
The correlation between development of hypocalcaemia in patients after total thyroidectomy with the following factors:
- Gender,
- Age,
Intraoperative factors:
- Intraoperative recognition of parathyroid glands
- Possible autotransplantation of parathyroid glands
- Using scissors, ultrasonic Ligasure compared using ultrasonic scissors
- use Ultracision ligation
- Use of hemostatic
- Volume of blood loss;
- Volume and weight; preparation
Postoperative factors based on the histological-pathological report:
-Underlying thyroid pathology
CHOICE / NUMBER OF PATIENTS:
At least 80 patients with any thyroid pathology undergoing a total thyroidectomy regardless of gender, age and medication preceding the one exception, patients treated with substitutes calcium and vitamin D.
METHODS (CLINICAL-LABORATORY) The hypocalcaemia is defined in the study as clinical hypocalcaemia. Required symptoms of hypocalcaemia are regional or perioral numbness and signs of hypocalcaemia: Trousseau sign (karpopodic spasm) and Chvostek sign (spasm CN VII) and / or the levels of free serum calcium below 0,5 mg / dl lower than the normal price laboratory (8,2-10,6 mg / dl).
Each patient included in the study is provided with:
- Detailed preoperative history and physical examination. Recording; all preoperative examinations before the introduction of the clinical (U / S thyroid scan, FNA biopsy)
- Receiving laboratory examinations
- Preoperative
- on the 6th, 12th and 24th postoperative hours,
- every 24 hours after the first 24 hours as long a patient remains in clinical
- at least 7 days after hospital discharge
- The laboratory control, includes
- pre-operatively and 6hr postoperatively :
- Complete blood count,
- levels of urea,
- creatinine,
- sodium potassium,
- glucose, -
- albumin,
- total protein, -
- transaminases,
- γ-GT,
- total and immediate cholerethrini,
- alkaline phosphatase,
- lactate dehydrogenase,
- amylase,
- free serum calcium,
- phosphorus,
- magnesium
- Ιn all other measurements:
- Free serum calcium,
- phosphorus,
- magnesium,
- albumin and
- total albumin levels
- Surgery information, detailed references of:
- The time of onset and completion of surgery
- The use of ligation, Ligasure ultrasonic scissors or Harmonic
- The recognition of intraoperative parathyroid glands, their number and their potential autologous transplants
- The weight of the specimen
- The blood loss (large or small)
- The use of hemostatics
- The use neuromonitoring
- The type of antibiotics used
- The technical rehabilitation of the skin and the use of skin glue
- The installation of vacuum drainage
- Detailed list of all medication received by the patient during hospitalization
- No intravenous or oral calcium or vitamin D supplementation before completing 12 hours postoperatively except the clinical case of development of significant hypocalcaemia.
- Detailed clinical examination, including:
- Testing for Regional numbness
- Monitored for signs of Chvostek and Trousseau
- Detailed analysis of the histological-pathological report with a detailed record of findings of the final pathology of the thyroid.
- Conditions
- Hypocalcemia After Total Thyroidectomy
- Keywords
- hypocalcemia, total thyroidectomy
- Medical subject headings
- Hypocalcemia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| patients with positive slope | patients with positive slope in the levels of free serum calcium levels between 6th and 12th postoperative hour | |
| patients with negative or no slope | patients with negative or no slope in the levels of free serum calcium levels between 6th and 12th postoperative hour. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Correlation of the variability of the levels of free serum calcium (Ca + +), between two measurements on 6 and 12 hours postoperatively, the incidence of hypocalcaemia in patients undergoing total thyroidectomy for any reason.
Measured: 6hr, 12hr, 24hr, 48hr postopreratively
Secondary outcomes (4)
The correlation between development of hypocalcaemia in patients after total thyroidectomy with the following factors: · Gender, · Age,
The correlation between development of hypocalcaemia and the Intraoperative recognition of parathyroid glands and possible autotransplantation of parathyroid glands,
The correlation between development of hypocalcaemia in patients after total thyroidectomy with the Underlying thyroid pathology based on the histological-pathological report:
The correlation between development of hypocalcaemia in patients after total thyroidectomy with the following factors: Use of Ligasure use of Ultracision, Use of hemostatic,Volume of blood loss, Volume and weight of specimen
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Dec 2009 (estimated)
- Study startNov 2008
- Primary completionJun 2010 (estimated)
- Study completionJan 2011 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Hypocalcemia After Total ThyroidectomyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 120 participants (estimated)
Sponsor and investigators
- Lead sponsor
- G. Hatzikosta General Hospital
- Sponsor type
- University, hospital or other
- Investigators
- Evangelos K Tsimoyiannis, DR, MD, FACS, FABI,, Study director, G. Hatzikosta General Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01027091
- Sponsor's protocol ID
- 7/06-11-09
- Status last verified
- Nov 2009
- First submitted
- 4 Dec 2009
- Last updated
- 7 Dec 2009
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 7 Dec 2009. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Study of a Safe and Cost-effective Method to Identify Patients at Low Risk for the Development of Significant Hypocalcemia After Total Thyroidectomy.
- ClinicalTrials.gov ID
- NCT01027091
- Acronym / sponsor ID
- 7/06-11-09
- Conditions
- Hypocalcemia After Total Thyroidectomy
- Keywords
- hypocalcemia, total thyroidectomy
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 120 participants (estimated)
- Lead sponsor
- G. Hatzikosta General HospitalUniversity, hospital or other
- Study start
- Nov 2008
- Primary completion
- Jun 2010 (estimated)
- Study completion
- Jan 2011 (estimated)
- First posted
- 7 Dec 2009 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Hypocalcemia is the complication, after total thyroidectomy, that usually determines the length of hospital stay.Serum calcium levels is a quick and cost-effective practice to recognise hypocalcemia in the postoperative follow up.
OBJECTIVE: The objective of this perspective study is to determine if consecutive postoperative serum calcium levels early after total thyroidectomy can be used to identify patients who are unlikely to develop significant hypocalcemia and can be safely discharged within 24 to 48 hours postoperative.
Detailed description
INTRODUCTION:
In recent years there has been a global trend towards more radical and aggressive approach to thyroid surgery (total or subtotal thyroidectomy against semithyreoeidectomy), almost regardless of the pathological cause, even for benign diseases. There is also developed, a serious skepticism as complications of total or subtotal thyroidectomy is neither rare nor insignificant. In particular, complications of thyroidectomy is the laryngeal nerve paresis (0.2% bilateral, unilateral 3,7-3,9%, 2% transient, lasting 1%), bleeding (1-2%), infection of the wound (0, 3-1,6%) and hypocalcaemia (permanent hypocalcaemia in over 6 months follow up 1,7-4,4%, while transient, manageable with vit D and calcium substitution 8,3-9,9%). The post total thyroidectomy hypocalcaemia is not only more frequent but also has the most delayed onset after surgery (up to several 24hours later) in relation to bleeding and paresis of the laryngeal nerve, which is immediate postoperative complications. This is the main cause of prolonged hospitalization and monitoring of patients postoperatively which is linked to increased risk of bacterial infections and increased cost.9, 10 Great effort has been made in the last 15 years to reduce the length hospital stay of patients in order to perform the total thyroidectomy as a one day surgery.6, 11 In this way great importance is the prediction of those patients are more likely to experience post-operative hypocalcaemia. The appearance of postoperative hypocalcaemia associated with specific diseases such as thyroid disease Graves, the thyreotoxicosis and thyroid cancer 7.8, and the surgical technique (the extent of excision, the type of thyroid artery ligation, the number of parathyroid recognized intraoperative but also those autotransplanted) 12. Moreover, beyond these factors, great importance is given to methods of monitoring patients to find reliable indicators to allow safe release out of the hospital after the first 24 hours without risk of hypocalcaemia. The measurement of parathyroid hormone (PTH) both intraoperative and postoperatively (4 hours) is a hot topic in contemporary literature and promises accurate predictions 13, but there is disagreement about the precise time of receiving the specimens and great consideration about the increased cost 14, 15 (at our hospital is not even available). An older, simple, fast and economical method is to measure levels of free serum calcium 6,9. Despite that the correlation of the immediate post-operative levels of free calcium, with the likelihood of developing hypocalcaemia has variations in different surveys, resulting to early release of patients directly when free calcium is in normal range, by some departments, while others follow strict protocols of monitoring patients for days . However, the variation in the levels of free serum calcium between the first 6 and 12 postoperative hours alone or in combination with measurement of PTH seems to give some answers and it is under great consideration in the international community.
It is therefore, in line with the current literature, important to develop a safe, and also cost-effective protocol monitoring patients after total thyroidectomy, which, in combination with predisposing risk factors of hypocalcaemia, will predict low-risk patients for developing hypocalcaemia and allow secure release from the hospital.
PRIMARY OBJECTIVES:
The objective of this perspective study is to correlate the variability of the levels of free serum calcium (Ca + +), and also the levels of albumin (ALB), phosphorus (PO-3), magnesium (Mg) and total albumin (TPR), between two measurements on 6 and 12 hours postoperatively, the incidence of hypocalcaemia in patients undergoing total thyroidectomy for any reason. The aim is to develop on the basis of variation in levels of free serum calcium, a secure method of prediction and identification of low risk patients for developing hypocalcaemia providing an early release from hospital.
SECONDARY OBJECTIVES:
The correlation between development of hypocalcaemia in patients after total thyroidectomy with the following factors:
- Gender,
- Age,
Intraoperative factors:
- Intraoperative recognition of parathyroid glands
- Possible autotransplantation of parathyroid glands
- Using scissors, ultrasonic Ligasure compared using ultrasonic scissors
- use Ultracision ligation
- Use of hemostatic
- Volume of blood loss;
- Volume and weight; preparation
Postoperative factors based on the histological-pathological report:
-Underlying thyroid pathology
CHOICE / NUMBER OF PATIENTS:
At least 80 patients with any thyroid pathology undergoing a total thyroidectomy regardless of gender, age and medication preceding the one exception, patients treated with substitutes calcium and vitamin D.
METHODS (CLINICAL-LABORATORY) The hypocalcaemia is defined in the study as clinical hypocalcaemia. Required symptoms of hypocalcaemia are regional or perioral numbness and signs of hypocalcaemia: Trousseau sign (karpopodic spasm) and Chvostek sign (spasm CN VII) and / or the levels of free serum calcium below 0,5 mg / dl lower than the normal price laboratory (8,2-10,6 mg / dl).
Each patient included in the study is provided with:
- Detailed preoperative history and physical examination. Recording; all preoperative examinations before the introduction of the clinical (U / S thyroid scan, FNA biopsy)
- Receiving laboratory examinations
- Preoperative
- on the 6th, 12th and 24th postoperative hours,
- every 24 hours after the first 24 hours as long a patient remains in clinical
- at least 7 days after hospital discharge
- The laboratory control, includes
- pre-operatively and 6hr postoperatively :
- Complete blood count,
- levels of urea,
- creatinine,
- sodium potassium,
- glucose, -
- albumin,
- total protein, -
- transaminases,
- γ-GT,
- total and immediate cholerethrini,
- alkaline phosphatase,
- lactate dehydrogenase,
- amylase,
- free serum calcium,
- phosphorus,
- magnesium
- Ιn all other measurements:
- Free serum calcium,
- phosphorus,
- magnesium,
- albumin and
- total albumin levels
- Surgery information, detailed references of:
- The time of onset and completion of surgery
- The use of ligation, Ligasure ultrasonic scissors or Harmonic
- The recognition of intraoperative parathyroid glands, their number and their potential autologous transplants
- The weight of the specimen
- The blood loss (large or small)
- The use of hemostatics
- The use neuromonitoring
- The type of antibiotics used
- The technical rehabilitation of the skin and the use of skin glue
- The installation of vacuum drainage
- Detailed list of all medication received by the patient during hospitalization
- No intravenous or oral calcium or vitamin D supplementation before completing 12 hours postoperatively except the clinical case of development of significant hypocalcaemia.
- Detailed clinical examination, including:
- Testing for Regional numbness
- Monitored for signs of Chvostek and Trousseau
- Detailed analysis of the histological-pathological report with a detailed record of findings of the final pathology of the thyroid.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| patients with positive slope | – | –patients with positive slope in the levels of free serum calcium levels between 6th and 12th postoperative hour |
| patients with negative or no slope | – | –patients with negative or no slope in the levels of free serum calcium levels between 6th and 12th postoperative hour. |
Who may qualify
- Ages
- 16 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- patients with any thyroid pathology undergoing total thyroidectomy regardless of gender, age and medication
Key inclusion criteria (1 listed)
- patients with any thyroid pathology undergoing total thyroidectomy regardless of gender, age and medication
Key exclusion criteria (1 listed)
- patients treated with substitutes calcium and vitamin D.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Correlation of the variability of the levels of free serum calcium (Ca + +), between two measurements on 6 and 12 hours postoperatively, the incidence of hypocalcaemia in patients undergoing total thyroidectomy for any reason.
Time frame: 6hr, 12hr, 24hr, 48hr postopreratively
4 secondary outcomes
The correlation between development of hypocalcaemia in patients after total thyroidectomy with the following factors: · Gender, · Age,
The correlation between development of hypocalcaemia and the Intraoperative recognition of parathyroid glands and possible autotransplantation of parathyroid glands,
The correlation between development of hypocalcaemia in patients after total thyroidectomy with the Underlying thyroid pathology based on the histological-pathological report:
The correlation between development of hypocalcaemia in patients after total thyroidectomy with the following factors: Use of Ligasure use of Ultracision, Use of hemostatic,Volume of blood loss, Volume and weight of specimen
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Dec 2009.
Related trials for Hypocalcemia After Total Thyroidectomy
RecruitingObservational study
Postoperative Hypocalcemia After Thyroidectomy
Thyroid Nodule, Thyroid Dysfunction
Not yet recruiting
NIRAF-Guided Parathyroid Identification During Thyroidectomy
Hypocalcemia, Hypoparathyroidism
Not yet recruiting
COMPARISON OF THE EFFICACY BETWEEN PREOPERATIVE CALCIUM & VITAMIN D3 VERSUS CALCIUM SUPPLEMENTATION ALONE TO PREVENT POST OPERATIVE SYMPTOMATIC HYPOCALCEMIA AFTER TOTAL THYROIDECTOMY IN EUTHYROID PATIENTS
Postoperative Symptomatic Hypocalcemia Following Total Thyroidectomy
RecruitingPhase 3
Contribution of ICG Angiography in the Detection of Parathyroids and the Prevention of Hypoparathyroidism Post Total Thyroidectomy
Thyroid Diseases
Recruiting
Comparing PTeye-assisted Versus Conventional Total Thyroidectomy
Hypocalcemia, Parathyroid
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Evangelos K Tsimoyiannis, DR, MD, FACS, FABI, study director
G. Hatzikosta General Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Hypocalcemia After Total Thyroidectomy, run by G. Hatzikosta General Hospital at 1 site in Greece.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 7 Dec 2009. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact George A. Economou, M.D (0030265103294, georgeconomou@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Correlation of the variability of the levels of free serum calcium (Ca + +), between two measurements on 6 and 12 hours postoperatively, the incidence of hypocalcaemia in patients undergoing total thyroidectomy for any reason. (time frame: 6hr, 12hr, 24hr, 48hr postopreratively). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Dec 2009.